0
0
2/15/23 at 10:07pm
Organization
Contagionlive.com
Author
Nina Cosdon
41 words
0
Comments
The candidate, Ad26.RSV.preF–RSV preF protein vaccine, was 80.0% effective against severe disease and 69.8% effective against any RSV acute respiratory infection.
You are the first to view
https://www.contagionlive.com/view/janssen-s-rsv-protein-vaccine-candidate-proves-safe-and-effective-in-older-adults
Create an account
or login to join the discussion